Intrinsic Value of S&P & Nasdaq Contact Us

Annexon, Inc. ANNX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.00
+175.9%

Annexon, Inc. (ANNX) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 10 Buy.

The consensus price target is $16.00, representing an upside of 175.9% from the current price $5.80.

Analysts estimate Earnings Per Share (EPS) of $-0.96 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.01 vs est $-0.95 (missed -5.8%). 2025: actual $-1.34 vs est $-1.38 (beat +2.8%). Analyst accuracy: 96%.

ANNX Stock — 12-Month Price Forecast

$16.00
▲ +175.86% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Annexon, Inc., the price target is $16.00.
The average price target represents a +175.86% change from the last price of $5.80.

ANNX Analyst Ratings

Buy
10
Ratings
10 Buy
Based on 10 analysts giving stock ratings to Annexon, Inc. in the past 3 months
Rating breakdown
Buy
10 100%
100%
Buy
10 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — ANNX

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$1.01 vs Est –$0.95 ▼ 5.4% off
2025 Actual –$1.34 vs Est –$1.38 ▲ 2.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — ANNX

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message